Skip to main content
Premium Trial:

Request an Annual Quote

Accelrys Builds a Chem-Bio Data Spreadsheet for GSK

SAN DIEGO, Oct. 25 — Accelrys and GlaxoSmithKline announced on Thursday that they have been in collaboration to produce a so-called “Hits and Leads Chemically Aware Spreadsheet” to enable GSK scientists to access, analyze, and visualize vast amounts of chemical and biological data stored in GSK’s R&D databases.

The technology is based on Accelrys’s Accord Grid Control, a tool for displaying multiple structures and reactions, as well as other data, in a grid format. The Grid Control was used as the basis of the data query and visualization tools and was interfaced to tools developed by GSK for uniting their databases.

Slava Budin-Jones, program manager at GSK said in a statement that Accelrys responded quickly to GSK’s request to work on site to jointly develop the initial prototype. Jeremy Potter, product manager for developer tools at Accelrys, said that the Accord Grid Control gives developers the ability to handle groups of structures and data with flexibility within one component.

Accelrys is a wholly-owned subsidiary of Pharmacopeia.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.